Search

everythinglearnresearchcommunity

for

Search:↓

New pyrazole-based inhibitors show promise for treating metabolic diseases and other conditions.

Diphenylcyclopropenone is more effective and has fewer side effects than dinitrochlorobenzene for treating alopecia areata.

ADT, especially enzalutamide, may increase the risk of heart rhythm problems and sudden death in men.

Topical diphencyprone effectively treated a 9-year-old boy's alopecia areata with fewer side effects.

Tolvaptan can slow kidney disease progression, but doesn't affect mortality or kidney failure.

Hair dye ingredient PPD can cause severe allergic reactions, including facial swelling.

LDE225 is a promising skin-applied treatment for basal cell carcinoma with good skin penetration and effectiveness.

Yuperio combined with bisoprolol improves heart function in patients with dilated cardiomyopathy.

dAR-6–1 is a promising new treatment for hair loss that works better than minoxidil.

Disitamab vedotin and gemcitabine effectively treated bladder cancer without major side effects.

Delta-opioid receptors affect skin cell circadian rhythms, possibly impacting wound healing and cancer.

Dupilumab may help children with alopecia areata and atopic dermatitis regrow hair.

Finasteride may cause sexual and psychological side effects by affecting an enzyme related to epinephrine.

The new anti-acne treatment HA-P5 effectively reduces acne by targeting two key receptors and avoids an enzyme that can hinder treatment.

Inhibiting PDE8A may help treat hair loss by boosting fat cell growth and hair regeneration.

Some dibenzo compounds might help treat cancer with fewer side effects.

The new compound may be a safer alternative to finasteride for prostate protection.

Polymeric micelle nanocarriers deliver adapalene more effectively to hair follicles than commercial products.

Compounds 15, 20, and 25 are strong inhibitors of human steroid 5α-reductase type 2.

Dutasteride may help prevent prostate cancer, but more research is needed.

Dupilumab significantly improved a 5-year-old girl's prurigo nodularis without side effects.

LX-38 is a safer drug option for treating prostate issues and hair loss without hormonal side effects.

PDRN may reduce inflammation and complications in revision rhinoplasty for patients with high fibrinogen levels.

Alpha-difluoromethylornithine prevents cancer in mice but causes hair loss.

Pentoxifylline effectively improves pretibial pruritic papular dermatitis.

LY320236 is a strong blocker of two enzymes that change testosterone into dihydrotestosterone and might help treat conditions related to male hormones.

The DPCP/HPβCD complex improves solubility and anti-inflammatory effects for alopecia areata treatment.

Dobutamine does not mimic dopamine at therapeutic doses but may at very high concentrations; microfilaments, not microtubules, are important for wound healing in Xenopus embryos.

A new compound may treat benign prostatic hyperplasia better than finasteride.

Deucravacitinib did not significantly improve hair regrowth in alopecia areata patients.